Biofilm Pharma

Platinum Sponsor

BioFilm Pharma brings its innovative approach by addressing the chronic disease and long-term treatment “diabete foot ulcers” (15 million new patients each year), which represent a heavy cost for Health Care system in high-income countries ($4 billions). BioFilm Pharma holds the unique proprietary technology to develop first-in-class products able to prevent and cure the metastatic bacterial infections named biofilms considered as the new paradigm in the antibiotherapy. We have already 45 compound families (Small molecules, NCE) in our pipeline and are 3 years up to proof-of-concept in patients for potential blockbusters.


GET INVOLVED AT

WORLD ANTI-MICROBIAL RESISTANCE CONGRESS

 

To Sponsor Or Exhibit

 


André Singer
andre.singer@terrapinn.com
+1 646.619.1797

 

 

Press & Media Partnerships

 


Shannon McGorry
shannon.mcgorry@terrapinn.com
+1 646.619.1840

 

 

To Speak

 


Claire Murphy
claire.murphy@terrapinn.com
+1 646.619.1784

 

Sign Up for Event Updates